Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Idiopathic Pulmonary Fibrosis

Known as: Idiopathic Pulmonary Fibrosis [Disease/Finding], Usual Interstitial Pneumonia, pulmonary fibrosis idiopathic 
Interstitial pneumonia characterized by the presence of fibrosis in the interstitial lung tissue. The pathologic diagnosis is based on the… Expand
National Institutes of Health

Related topics

Related topics

26 relations

Broader (5)

Acute DiseaseAlveolitisChronic diseaseLung Diseases, Interstitial
Expand
Acute interstitial pneumoniaAutosomal dominant inheritanceCentriacinar EmphysemaChest
Expand

Narrower (1)

Chronic idiopathic pulmonary fibrosis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2020
Highly Cited
2020
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Summary Background Since December, 2019, Wuhan, China, has… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Highly Cited
2014
Highly Cited
2014
Idiopathic pulmonary fibrosis.
  • S. Rosselot
  • Nursing standard (Royal College of Nursing (Great…
  • 2014
    • Corpus ID: 774874
The most common signs and symptoms of idiopathic pulmonary fibrosis are shortness of breath and a persistent dry, hacking cough… Expand
Highly Cited
2014
Highly Cited
2014
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
BACKGROUND In two of three phase 3 trials, pirfenidone, an oral antifibrotic therapy, reduced disease progression, as measured by… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Highly Cited
2012
Highly Cited
2012
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
BACKGROUND Blockade of programmed death 1 (PD-1), an inhibitory receptor expressed by T cells, can overcome immune resistance. We… Expand
  • table 2
  • table 2
Highly Cited
2011
Highly Cited
2011
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
This document is an international evidence-based guideline on the diagnosis and management of idiopathic pulmonary fibrosis, and… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Highly Cited
2011
Highly Cited
2011
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
BACKGROUND Idiopathic pulmonary fibrosis is a progressive and fatal lung disease with inevitable loss of lung function. The… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Review
2001
Review
2001
Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy
Idiopathic pulmonary fibrosis is a specific form of chronic fibrosing interstitial pneumonia limited to the lung. Although its… Expand
Highly Cited
2000
Highly Cited
2000
Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement
Many acute and chronic lung disorders with variable degrees of pulmonary inflammation and fibrosis are collectively referred to… Expand
Review
1998
Review
1998
Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.
Background Pathologic Classification of Idiopathic Pulmonary Fibrosis UIP DIP/Respiratory Bronchiolitis Interstitial Lung Disease… Expand
  • table 2
  • table 3
  • table 1
  • table 4
  • table 5
Highly Cited
1959
Highly Cited
1959
Statistical aspects of the analysis of data from retrospective studies of disease.
The role and limitations of retrospective investigations of factors possibly associated with the occurrence of a disease are… Expand
  • table I
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE